Academy of Managed Care Pharmacy (AMCP) CEO Susan Cantrell in a blog post says the AMCP Format 4.1 features new sections that highlight the evidence needs of health care decision-makers regarding unapproved products.
The updated format, which was presented during Nexus 2019, factors in current regulations on information which can be provided by manufacturers.
“Those regulations go only so far, though, and they are subject to change based on judicial decisions or regulatory winds,” she writes. “For that reason, AMCP continues to spearhead efforts to codify these regulations through Congressional action; we want to be sure that this information remains available and that companies know the law permits them to respond to our requests.”
To read the full blog post, click here.
